66 filings
Page 2 of 4
8-K
3lor7qjhnm6k h8j9uh
29 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
ssv6u43
9 Nov 23
Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update
5:15pm
8-K
9cb trxrq624e
2 Nov 23
Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules
5:10pm
8-K
1p6v44i8kjfa6 9hy
13 Oct 23
Entry into a Material Definitive Agreement
5:26pm
8-K
idyfk7oo
10 Oct 23
Patent Application Filed with Potential to Extend AmeluzĀ® Protection to 2043
9:15am
8-K
hrx7eeu6o neg707xw2
4 Oct 23
Biofrontera Inc. Announces Preliminary Third Quarter Revenues
8:45am
8-K
zho5v67no1mugn5
3 Oct 23
Other Events
5:17pm
8-K
i7brumqx7mbccr
11 Aug 23
Biofrontera Inc. Reports Second Quarter 2023 Financial Results and Provides a Business Update
7:30am
8-K
iq08j22xt 27g1mta
13 Jul 23
Management Reaffirms Full-Year 2023 Revenue Growth of at least 25% over Prior Year
12:00am
8-K
g2xek2
12 Jul 23
Biofrontera Inc. Appoints Dr. Heikki Lanckriet to its Board of Directors
8:44am
8-K
gky 4uega6glhr1
3 Jul 23
Biofrontera Inc. Announces 1-for-20 Reverse Stock Split
9:25am
8-K
apdwbqsf
20 Jun 23
Changes in Registrant's Certifying Accountant
4:30pm
8-K
mvdotond2 vvqniqq
2 Jun 23
Changes in Registrant's Certifying Accountant
5:00pm
8-K
eiu9yn2vlln7iq6qfa0
1 Jun 23
Biofrontera Inc. Begins Development of a Portable Photodynamic Therapy Lamp for Use with AmeluzĀ®-PDT
9:15am
8-K
bibswkb9xe43lfq9aqy
30 May 23
Biofrontera Inc. Names Founder and Executive Chairman Hermann
9:00am
8-K
xp3rv0pv
26 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:12pm
8-K
gbmhbhqygjpoiqdn8o
12 May 23
Biofrontera Inc. Reports First Quarter 2023 Financial Results and Provides a Business Update
8:09am
8-K
h61vq0ifgupjc9 tryp
28 Apr 23
Entry into a Material Definitive Agreement
8:22am
8-K
vxavv5nk
17 Apr 23
Entry into a Material Definitive Agreement
5:25pm
8-K
3qq7z165
8 Mar 23
Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results
4:15pm